Abstract
The author’s laboratory studies interactions between human T lymphocytes and vascular endothelial cells (EC). Our work is organized around three hypotheses. First, we propose that vascular EC can initiate secondary (i.e., recall) immune reactions by presenting antigenic peptide-major histocompatibility complex (MHC) complexes to those circulating memory T cells whose cognate antigen is locally present within a peripheral tissue, e.g., as a consequence of infection or allogeneic transplantation. In this way, EC can increase the efficiency of immune surveillance. Second, we propose that T cell signals, both secreted (e.g., cytokines) and contact-dependent (e.g., CD40 ligand), activate new gene expression in EC that induce the capacity to perform new effector functions, such as leukocyte recruitment and activation or initiation of intravascular coagulation. In this way, EC can particpate as effector cells for cell-mediated immune reactions. Third, we propose that EC are major targets of immune-mediated injury. Consequently, increasing resistance of endothelium to immune effector mechanisms may protect tissues from damage, e.g., in allograft rejection. These three hypotheses are explored through in vitro experiments, through analyses of human tissue specimens, and through in vivo studies employing novel human-mouse chimeric animals.
Similar content being viewed by others
References
Cines DB, Pollak EA, Buck CA, Loscalzo J, Zimmerman GA, McKever RP, et al.: Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998;91:3527–3561.
Pober JS, Gimbrone MA, Jr., Cotran RS, Reiss CS, Burakoff SJ, Fiers W, et al.: Ia expression by vascular endothelium is inducible by activated T cells and by human gammainterferon. J Exp Med 1983;157: 1339–1353.
Messadi DV, Pober JS, Murphy GF: Effects of recombinant gamma interferon on HLA-DR and DQ expression by skin cells in short term organ culture. Lab Invest 1988;58:61–67.
Wang M, Pober JS, Johnson DR: Interferon induction of TAP1: The phosphatase SHP-1 regulates crossover between the IFN-α/Β and the IFN-γ signal tranduction pathways. Circulation Res 1998;80:815–823
Wang M, Pober JS, Johnson DR: Kinetically-coordinated induction of TAP1 and HLA class I by IFN-γ: the rapid induction of TAP1 by IFN-γ is mediated by STAT1α. J Immunol 1996; 156:3174–3183.
Johnson DR, Pober JS: Tumor necrosis factor and immune interferon synergistically increase transcription of HLA class I heavy and light chain genes in vascular endothelium. Proc Natl Acad Sci USA 1990;87:5183–5187.
Collins T, Korman AJ, Wake CT, Boss JM, Kappes DJ, Fiers W, et al.: Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts. Proc Natl Acad Sci USA 1984;81:4917–4921.
Wagner CR, Vetto RM, Burger DR: The mechanism of antigen presentation by endothelial cells. Immunobiology 1984; 168:453–469.
Epperson DE, Pober JS: Antigenpresenting function of human endothelial cells: direct activation of resting CD8 T cells. J Immunol 1994;153:5042–5412.
Pober JS, Collins T, Gimbrone MA, Jr., Cotran RS, Gitlin JD, Fiers W, et al.: Lymphocytes recognize human vascular endothelial and dermal fibroblast Ia antigens induced by recombinant immune interferon. Nature 1983;305:726–729.
Murray AG, Petzelbauer P, Hughes CCW, Costa J, Askenase P, Pober JS: Human T cell-mediated destruction of allogeneic dermal microvessels in a SCID mouse. Proc Natl Acad Sci USA 1994;91:9146–9150.
Karmann K, Hughes CCW, Schechner J, Fanslow WC, Pober JS: CD40 on human endothelial cells: Inducibility by cytokines and functional regulation of adhesion molecule expression. Proc Natl Acad Sci USA 1995;92:4342–4346.
Maher SE, Karmann K, Min W, Hughes CCW, Pober JS, Bothwell ALM: Porcine endothelial CD86 is a major costimulator of xenogeneic human T cells: cloning, sequencing and functional expression in human endothelial cells. J Immunol 1996; 157:3838–3844.
Ma W, Pober JS: Human endothelial cells effectively costimulate cy tokine production by but not differentiation of naive CD4+ T cells. J Immunol 1998;161:2158–2167.
Valitutti S, Muller S, Cella M, Padovan E, Lanzavecchia A: Serial triggering of many T-cell receptors by a few peptide-MHC complexes. Nature 1995;375:148–151.
Hughes CCW, Savage COS, Pober JS: Endothelial cells augment T cell IL-2 production by a contactdependent mechanism involving CD2:LFA-3 interaction. J Exp Med 1990;171:1453–1467.
Savage COS, Hughes CCW, Pepinsky RS, Wallner BP, Freedman AS, Pober JS: Endothelial cell lymphocyte function-associated antigen3 and an unidentified ligand act in concert to provide costimulation to human peripheral blood CD4+ T cells. Cell Immunol 1991;137: 150–163.
Karmann K, Hughes CCW, Fanslow WC, Pober JS: Endothelial cells augment the expression of CD40 ligand on newly activated human CD4+ T cells through a CD2/LFA-3 signaling pathway. Eur J Immunol 1996;26:610–617.
Biedermann B, Pober JS: Endothelial cells induce and regulate cytolytic T cell differentiation. J Immunol 1998; in press.
Murray AG, Schechner JS, Epperson DE, Sultan P, McNiff JM, Hughes CCW, et al.: Dermal microvascular injury in the human peripheral blood lymphocytes reconstituted-severe combined immunodeficient (HuPBL-SCID) mouse/ skin allograft model is T cell mediated and inhibited by a combination of cyclosporine and rapamycin. Am J Pathol 1998; 153:627–638.
Sultan P, Schechner JS, McNiff JM, Hochman PS, Hughes CCW, Lorber MI, et al.: Blockade of CD2-LFA-3 interactions protects human skin allografts in immunodeficient mouse/human chimeras. Nature Biotechnology 1997; 15:759–762.
Pober JS, Cotran RS: Overview: the role of endothelial cells in inflammation. Transplantation 1990;50:537–544.
Pober JS, Cotran RS:Cytokines and endothelial cell biology. Physiol Rev 1990;70:427–451.
Stolpen AH, Guinan EC, Fiers W, Pober JS: Recombinant tumor necrosis factor and immune interferon act singly and in combination to reorganize human vascular endothelial cell monolayers. Am J Pathol 1986;123:16–24.
Petzelbauer P, Bender JR, Wilson J, Pober JS: Heterogeneity of dermal microvascular endothelial cell antigen expression and cytokine responsiveness in situ and in cell culture. J Immunol 1993;151: 5062–5072.
DeLuca LG, Johnson DR, Whitley MZ, Collins T, Pober JS: cAMP and TNF competitively regulate transcriptional activation through and nuclear factor binding to the CRE/ATF element of the endothelial leukocyte adhesion molecule1 (E-selectin) promoter. J Biol Chem 1994;30: 19,193–19,196.
Karmann K, Wang M, Fanslow WC, Pober JS: Activation and homologous desensitization of human endothelial cells by CD40 ligand, tumor necrosis factor, and interleukin 1. J Exp Med 1996; 184:173–182.
Wang M, Pober JS: TNF initiates E-selectin transcription in human endothelial cells through parallel TRAF-NF-κB and TRAF-RAC/ CDC42-JNK-cJun/ATF-2 pathways. J Immunol 1997; 159:3508 -3518.
Slowik MR, DeLuca LG, Fiers W, Pober JS: Tumor necrosis factor (TNF) activates human endothelial cells through the p55 TNF receptor but the p75 receptor contributes to activation at low TNF concentration. Am J Pathol 1993; 134:1724–1730.
Jones SJ, Ledgerwood EC, Prins JB, Savidge J, Johnson DR, Pober JS, et al.: TNF recruits TRADD to the plasma membrane but not the trans-Golgi network, the principal subcellular location of TNF-R1. J Immunol 1998; in press.
Bradley JR, Thiru S, Pober JS: Disparate localization of 55kd and 75kd TNF receptors in human endothelial cells. Am J Pathol 1994; 146:27–32.
Pober JS: Activation and injury of endothelial cells by cytokines. Pathol Biol 1998;46:159–163.
Wang M, Bradley JR, Galbraith JJ, Jones SJ, Ledgerwood EC, Pober JS: The N-terminal domains target TRAF2 to the nucleus and display transcriptional regulatory activity. JImmunol 1998;161: 319–324.
Ledgerwood EC, Prins JB, Bright N, Johnson DR, Wolfreys K, Pober JS, et al.: TNF is delivered to mitochondria where a TNF binding protein is localized. Lab Invest 1998; in press.
Doukas J, Pober JS: IFN-γ enhances endothelial activation induced by TNF but not IL-1. J Immunol 1990;145:1727–1733.
Kluger MS, Johnson DR, Pober JS: Mechanism of sustained E-seletin expression in cultured human dermal microvascular endothelial cells. J Immunol 1997;158:887–896.
Pober JS: Vascular endothelium in transplantation, in Tilney NL, Strom TB, Paul LC (eds.): Transplantation Biology: Cellular & Molecular Aspects. New York, Raven Press, 1996, pp. 127–136.
Bombeli T, Karsan A, Tait JF, Harlan JM: Apoptotic vascular endothelial cells become procoagulant. Blood 1997;89: 2429–2442.
Slowik M, Wang M, Ardito T, Karsan A, Kashgarian M, Pober JS: Evidence that TNF triggers apoptosis in human endothelial cells by ICE-like protease-dependent and -independent pathways. Lab Invest 1997;77:257–267.
Lorber MI, Wilson JH, Robert ME, Schecher JS, Kirkiles N, Qian HY, et al.: Human allogeneic vascular rejection after arterial transplantation and peripheral lymphoid reconstitution in SCID mice. Transplantation 1998; in press.
Murray AG, Khadadoust MM, Pober JS, Bothwell ALM: Porcine aortic endothelial cells strongly activate human T cells: direct presentation of swine MHC antigens and effective co-stimulation by swine ligands for human CD2 and CD28. Immunity 1994;1:57–63.
Sultan P, Murray AG, McNiff JM, Lorber MI, Askenase PW, Bothwell ALM, et al.: Pig but not human Interferon-γ initiates human cellmediated rejection of pig tissue in vivo. Proc Natl Acad Sci (USA) 1997;94:8767–8772.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pober, J.S. Immunobiology of human vascular endothelium. Immunol Res 19, 225–232 (1999). https://doi.org/10.1007/BF02786490
Issue Date:
DOI: https://doi.org/10.1007/BF02786490